Spotlight On... First Spectral CT installed by Philips in Dutch hospital; FDA clears novel bladder cancer telescope; Intact Vascular reports positive below-the-knee angioplasty data; and more...

Royal Philips ($PHG) has installed the first spectral detector-based computed tomography (CT) system at the University Medical Center Utrecht. It's designed to offer multiple layers of diagnostic data in a single, low-dose scan. "Unlike traditional CT images, which can be limited in structural detail and require additional scans, Philips' IQon Spectral CT allows our clinicians to identify the composition of materials in the body in one scan," said Tim Leiner of the Imaging Division at UMC Utrecht in a statement. "In a patient-focused care environment, comprehensive solutions that enable 'first-time right' testing and diagnostics without compromises can be revolutionary in addressing many of our greatest challenges, including workflow and patient satisfaction." More

> The FDA has cleared a new high-definition telescope to improve bladder cancer visualization from Olympus. It's the first to market of Extra-Low Dispersion (ED) Glass for rigid surgical endoscopy, according to the company. More

> Pennsylvania startup Intact Vascular has disclosed positive 12-month outcomes results for Tack Endovascular System for balloon angioplasty below the knee.  More

> A new study has found that patients with pacemakers and sleep apnea are at increased risk of atrial fibrillation. More

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.